Acute Respiratory Distress Syndrome Clinical Trial
Official title:
Evaluation of Respiratory Mechanics and Lung Recruitment in Patients With SARS-CoV-2 Associated Acute Respiratory Distress Syndrome
NCT number | NCT04350710 |
Other study ID # | 2030/31 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 18, 2020 |
Est. completion date | December 31, 2020 |
The aim of this observationnal study is to describe respiratory mechanics and lung recruitement in patients with SARS-CoV-2 Associated Acute Respiratory Distress Syndrome who underwent invasive ventilation on endotracheal tube, admitted to the medical ICU of Angers university hospital . Statics measurements of respiratory system compliance were performed at 2 differents levels of PEEP (15 cmH2O and 5 cmH2O). The recruited volume is computed as the difference between the volume expired from PEEP 15 to 5 cmH2O and the volume predicted by compliance at PEEP 5 cmH2O . The recruitment-to-Inflation (R/I) ratio (i.e. the ratio between the recruited lung compliance and CRS at PEEP 5 cmH2O) is used to assess lung recruitability. A R/I ratio value higher than or equal to 0.5 was used to define highly recruiter patients.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | December 31, 2020 |
Est. primary completion date | April 20, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - ARDS criteria according to Berlin classification criteria - Invasive mechanical ventilation on endotracheal tube - SARS Cov-2 infection Exclusion Criteria: - pneumothorax |
Country | Name | City | State |
---|---|---|---|
France | CHU | Angers |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Angers |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment-to Inflation ratio (R/I ratio) | no unit | Day 1 | |
Primary | Recruitment-to Inflation ratio (R/I ratio) | no unit | Day 5 | |
Primary | Recruitment-to Inflation ratio (R/I ratio) | no unit | Day 10 | |
Secondary | PaO2/FiO2 (mmHg) | Arterial blood gases | Day 1 | |
Secondary | PaO2/FiO2 (mmHg) | Arterial blood gases | Day 5 | |
Secondary | PaO2/FiO2 (mmHg) | Arterial blood gases | Day 10 | |
Secondary | Lung volume recruited (VRec) | mL | Day 1 | |
Secondary | Lung volume recruited (VRec) | mL | Day 5 | |
Secondary | Lung volume recruited (VRec) | mL | Day 10 | |
Secondary | Plateau pressure (cm H2O) | Obtained by inspiratory pause of 5 seconds | Day 1 | |
Secondary | Plateau pressure (cm H2O) | Obtained by inspiratory pause of 5 seconds | Day 5 | |
Secondary | Plateau pressure (cm H2O) | Obtained by inspiratory pause of 5 seconds | Day 10 | |
Secondary | Oesophagal pressure (cm H2O) | Day 1 | ||
Secondary | Oesophagal pressure (cm H2O) | Day 5 | ||
Secondary | Oesophagal pressure (cm H2O) | Day 10 | ||
Secondary | weight (Kg) | Day 1 | ||
Secondary | weight (Kg) | Day 5 | ||
Secondary | weight (Kg) | Day 10 | ||
Secondary | urine output (mL) | day 1 | ||
Secondary | urine output (mL) | day 5 | ||
Secondary | urine output (mL) | day 10 | ||
Secondary | serum creatinine (Umo/L) | day 1 | ||
Secondary | serum creatinine (Umo/L) | day 5 | ||
Secondary | serum creatinine (Umo/L) | day 10 | ||
Secondary | Mean arterial pressure (mmHg) | day 1 | ||
Secondary | Mean arterial pressure (mmHg) | day 5 | ||
Secondary | Mean arterial pressure (mmHg) | day 10 | ||
Secondary | Peak Pressure (cm H2O) | Day 1 | ||
Secondary | Peak Pressure (cm H2O) | Day 5 | ||
Secondary | Peak Pressure (cm H2O) | Day 10 | ||
Secondary | PEEP total (cm H2O) | Obtained by expiratory pause of 5 seconds | Day 1 | |
Secondary | PEEP total (cm H2O) | Obtained by expiratory pause of 5 seconds | Day 5 | |
Secondary | PEEP total (cm H2O) | Obtained by expiratory pause of 5 seconds | Day 10 | |
Secondary | PEP Set (cm H2O) | Day 1 | ||
Secondary | PEP Set (cm H2O) | Day 5 | ||
Secondary | PEP Set (cm H2O) | Day 10 | ||
Secondary | Height (cm) | Day 1 | ||
Secondary | Airway pening pressure (cm H2O) | day 1 | ||
Secondary | Airway pening pressure (cm H2O) | day 5 | ||
Secondary | Airway pening pressure (cm H2O) | day 10 | ||
Secondary | Expired volume in PEEP setted at 15 cmH2O (mL) | respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted | Day 1 | |
Secondary | Expired volume in PEEP setted at 15 cmH2O (mL) | respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted | Day 5 | |
Secondary | Expired volume in PEEP setted at 15 cmH2O (mL) | respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted | Day 10 | |
Secondary | Expired volume in PEEP setted at 5 cmH2O (mL) | respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted | Day 1 | |
Secondary | Expired volume in PEEP setted at 5 cmH2O (mL) | respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted | Day 5 | |
Secondary | Expired volume in PEEP setted at 5 cmH2O (mL) | respiratory rate decreased to 10 /min, expired tidal volume displayed by the ventilator is noted | Day 10 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Recruiting |
NCT05535543 -
Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
|
||
Completed |
NCT04695392 -
Restore Resilience in Critically Ill Children
|
N/A | |
Terminated |
NCT04972318 -
Two Different Ventilatory Strategies in Acute Respiratory Distress Syndrome Due to Community-acquired Pneumonia
|
N/A | |
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Completed |
NCT04078984 -
Driving Pressure as a Predictor of Mechanical Ventilation Weaning Time on Post-ARDS Patients in Pressure Support Ventilation.
|
||
Completed |
NCT04451291 -
Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure
|
N/A | |
Not yet recruiting |
NCT06254313 -
The Role of Cxcr4Hi neutrOPhils in InflueNza
|
||
Not yet recruiting |
NCT04798716 -
The Use of Exosomes for the Treatment of Acute Respiratory Distress Syndrome or Novel Coronavirus Pneumonia Caused by COVID-19
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04909879 -
Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome
|
Phase 2 | |
Not yet recruiting |
NCT02881385 -
Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation
|
N/A | |
Terminated |
NCT02867228 -
Noninvasive Estimation of Work of Breathing
|
N/A | |
Completed |
NCT02545621 -
A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
|
||
Completed |
NCT02232841 -
Electrical Impedance Imaging of Patients on Mechanical Ventilation
|
N/A | |
Withdrawn |
NCT02253667 -
Palliative Use of High-flow Oxygen Nasal Cannula in End-of-life Lung Disease Patients
|
N/A | |
Completed |
NCT02889770 -
Dead Space Monitoring With Volumetric Capnography in ARDS Patients
|
N/A | |
Withdrawn |
NCT01927237 -
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
|
N/A | |
Completed |
NCT01504893 -
Very Low Tidal Volume vs Conventional Ventilatory Strategy for One-lung Ventilation in Thoracic Anesthesia
|
N/A | |
Completed |
NCT01680783 -
Non-Invasive Ventilation Via a Helmet Device for Patients Respiratory Failure
|
N/A | |
Completed |
NCT02814994 -
Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients
|
N/A |